Arcutis Appoints Chris Peetz to Board of Directors
Arcutis Biotherapeutics appointed Chris Peetz to its board to support its growth strategy. The move aims to leverage his extensive experience in building and scaling biopharmaceutical organizations.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed